1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6348796B211FF2D16852571C3005DB56E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-in-pharmaceutical-sales-force-effectiveness?OpenDocument
18
19OpenDocument
2052.23.234.7
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RC




Products & Services

Best Practices in Pharmaceutical Sales Force Effectiveness

ID: WP-37


Pages: 8


Published: Pre-2014


Delivery Format: Online


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Return to Sales Management Research and Consulting Page


Sales force effectiveness in the pharmaceutical industry helps drive business growth and value. Healthcare sector sales forces are finding it increasingly difficult to access and influence physicians, in large part due to the market saturation with competitor reps.

To build better trust with physicians, reps need to go beyond simply promoting a product: Reps not only need to add scientific value, tools, and services to their physician interactions but also convey the superior value of their product over the competitors.

This white paper highlights how sales representatives can actively drive sales volumes through patient education, disease management, and advocacy relations. Insights from the study would help drive sales force effectiveness in pharmaceutical companies.

For more information, please contact:
Ken Tyma, Head of Business Development, at (919) 767-9226 or via email

Industries Profiled:
Biotech; Pharmaceutical


Companies Profiled:
Various Pharma and Biotech